Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Haemonetics Corp
NYSE:HAE
Haemonetics Corp
NYSE:HAE
Price:
104.9
USD
0.51%
Market Closed
Market Cap:
$4.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Haemonetics Corp
NYSE:HAE
|
US |
|
Mandom Indonesia Tbk PT
IDX:TCID
|
ID |
|
SSP Group PLC
LSE:SSPG
|
UK |
|
Telus Corporation
TSX:T
|
CA |
|
Kingfisher Metals Corp
F:9700
|
CA |
|
Nitco Ltd
NSE:NITCO
|
IN |
|
C
|
Cognizant Technology Solutions Corp
XMUN:COZ
|
US |
|
M
|
Merck & Co Inc
XMUN:6MK
|
US |
|
Metals X Ltd
ASX:MLX
|
AU |
|
E
|
Ecolab Inc
DUS:ECJ
|
US |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
OTC:MDIBF
|
IT |
|
Terreno Realty Corp
NYSE:TRNO
|
US |
|
Brainsway Ltd
NASDAQ:BWAY
|
IL |
|
S
|
Sands China Ltd
SWB:599A
|
MO |
|
SEB SA
PAR:SK
|
FR |
|
Select Harvests Ltd
ASX:SHV
|
AU |
|
Esprit Holdings Ltd
HKEX:330
|
BM |
|
C
|
Centric Holdings SA
ATHEX:CENTR
|
GR |
|
Bellevue Gold Ltd
ASX:BGL
|
AU |
|
Q
|
QinetiQ Group PLC
F:QY6
|
UK |
Wall St Price Targets
HAE Price Forecast
Based on 11 analysts
Based on 11 analysts
+15% Upside
from
$104.9
today
Haemonetics Corp (HAE)’s 12-month stock price forecast through October 2027 has a consensus target of $120.36, implying 15% upside. The forecast is based on price targets from 11 Wall Street analysts.
HAE Analyst Rating
Based on 11 analysts
Based on 11 analysts
Analysts rate HAE Buy, with 9 of 11 recommending Buy or Strong buy.
Haemonetics Corp Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HAE's stock price target?
Price Target
120.36
USD
120.36
USD
According to Wall Street analysts, the average 1-year price target for HAE is 120.36 USD with a low forecast of 95.95 USD and a high forecast of 131.25 USD.
What is the Revenue forecast for Haemonetics Corp?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 4 years is 6%.
What is the Gross Profit forecast for Haemonetics Corp?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 4 years is 7%.
What is the Operating Income forecast for Haemonetics Corp?
Projected CAGR
18%
18%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 4 years is 18%.
What is the Pre-Tax Income forecast for Haemonetics Corp?
Projected CAGR
47%
47%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 47%.
What is the Net Income forecast for Haemonetics Corp?
Projected CAGR
36%
36%
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 4 years is 36%.